Henry E. Wiley
- Ophthalmology top 0.5%
- Retinal Diseases and Treatments 29
- Ocular Oncology and Treatments 9
- Retinal and Optic Conditions 9
- Glaucoma and retinal disorders 8
-
- Retinal Imaging and Analysis 21
- Oncology top 10%
- Immunology and Allergy top 10%
-
- Cancer, Hypoxia, and Metabolism 12
-
- Retinal Development and Disorders 9
-
- Ophthalmology and Visual Impairment Studies 5
- Co-authors
- Min‐Huan WuWusi C. MakiSam T. HwangEmily Y. ChewCatherine A. CukrasWai T. WongElvira AgrónFrederick L. Ferris
- Journals
- Ophthalmology (9 papers)Investigative Ophthalmology & Visual Science (6 papers)Translational Vision Science & Technology (6 papers)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Henry E. Wiley
56 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 86
- Ophthalmology 738
- Radiology, Nuclear Medicine and Imaging 496
- Oncology 312
- Immunology 214
- Immunology and Allergy 54
Countries citing papers authored by Henry E. Wiley
This map shows the geographic impact of Henry E. Wiley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry E. Wiley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry E. Wiley more than expected).
Fields of papers citing papers by Henry E. Wiley
This network shows the impact of papers produced by Henry E. Wiley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry E. Wiley. The network helps show where Henry E. Wiley may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Henry E. Wiley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2023 | 4 | |
| 4 | 2022 | 19 | |
| 5 | 2022 | 2 | |
| 6 | 2022 | 1 | |
| 7 | 2021 | 26 | |
| 8 | Oral HIF-2α inhibitor belzutifan for ocular von Hippel-Lindau (VHL) disease | 2021 | 4 |
| 9 | Correlations Between AMD Severity and OCT Thickness | 2021 | 1 |
| 10 | 2020 | 2 | |
| 11 | 2020 | 7 | |
| 12 | Ocular findings in a phase 2 trial testing the first-in-class oral HIF-2α inhibitor, PT2385, for renal cell carcinoma in von Hippel-Lindau disease | 2019 | 1 |
| 13 | Repeatability and Comparison of Dark Adaptation Using the Medmont DAC Perimeter and AdaptDx Dark Adaptometer | 2019 | 1 |
| 14 | 2018 | 178 | |
| 15 | 2018 | 110 | |
| 16 | Longitudinal Study of Dark Adaptation as a Functional Outcome Measure for Age-Related Macular Degeneration | 2016 | 1 |
| 17 | 2016 | 15 | |
| 18 | 2016 | 14 | |
| 19 | 2014 | 26 | |
| 20 | 1989 | 7 |
About Henry E. Wiley
Henry E. Wiley is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 60 papers that have together received 1.4k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (29 papers), Retinal Imaging and Analysis (21 papers), Cancer, Hypoxia, and Metabolism (12 papers), Ocular Oncology and Treatments (9 papers), Retinal and Optic Conditions (9 papers), Retinal Development and Disorders (9 papers), Glaucoma and retinal disorders (8 papers) and Ophthalmology and Visual Impairment Studies (5 papers). The work is most often cited by research in Ophthalmology (738 citations), Radiology, Nuclear Medicine and Imaging (496 citations) and Oncology (312 citations). Henry E. Wiley has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Min‐Huan Wu, Wusi C. Maki, Sam T. Hwang, Emily Y. Chew, Catherine A. Cukras, Wai T. Wong, Elvira Agrón, Frederick L. Ferris, Paul A. Sieving and Lisa L. Wei. Their work appears in journals such as Ophthalmology, Investigative Ophthalmology & Visual Science, Translational Vision Science & Technology, Ophthalmology Retina and Retina.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.